Benitec Biopharma Statistics Share Statistics Benitec Biopharma has 26.25M
shares outstanding. The number of shares has increased by 160.26%
in one year.
Shares Outstanding 26.25M Shares Change (YoY) 160.26% Shares Change (QoQ) 2.97% Owned by Institutions (%) 56.72% Shares Floating 24.55M Failed to Deliver (FTD) Shares 2,015 FTD / Avg. Volume 1.75%
Short Selling Information The latest short interest is 1.44M, so 5.63% of the outstanding
shares have been sold short.
Short Interest 1.44M Short % of Shares Out 5.63% Short % of Float 10.53% Short Ratio (days to cover) 14.28
Valuation Ratios The PE ratio is -3.43 and the forward
PE ratio is -4.86.
Benitec Biopharma's PEG ratio is
0.04.
PE Ratio -3.43 Forward PE -4.86 PS Ratio 344.9 Forward PS 8 PB Ratio 1.58 P/FCF Ratio -3.8 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Benitec Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.49,
with a Debt / Equity ratio of 0.01.
Current Ratio 10.49 Quick Ratio 10.49 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -24.88
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $13.5K Profits Per Employee $-1.36M Employee Count 16 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -619K Effective Tax Rate 2.77%
Stock Price Statistics The stock price has increased by 28.9% in the
last 52 weeks. The beta is 0.4, so Benitec Biopharma's
price volatility has been higher than the market average.
Beta 0.4 52-Week Price Change 28.9% 50-Day Moving Average 13.29 200-Day Moving Average 12.39 Relative Strength Index (RSI) 47.45 Average Volume (20 Days) 115,111
Income Statement In the last 12 months, Benitec Biopharma had revenue of 216K
and earned -21.75M
in profits. Earnings per share was -2.68.
Revenue 216K Gross Profit 108K Operating Income -22.49M Net Income -21.75M EBITDA -22.49M EBIT -21.75M Earnings Per Share (EPS) -2.68
Full Income Statement Balance Sheet The company has 50.87M in cash and 284K in
debt, giving a net cash position of 50.58M.
Cash & Cash Equivalents 50.87M Total Debt 284K Net Cash 50.58M Retained Earnings -190.26M Total Assets 105.21M Working Capital 96.98M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -19.4M
and capital expenditures -179K, giving a free cash flow of -19.58M.
Operating Cash Flow -19.4M Capital Expenditures -179K Free Cash Flow -19.58M FCF Per Share -1.91
Full Cash Flow Statement Margins Gross margin is 50%, with operating and profit margins of -10412.04% and -10069.91%.
Gross Margin 50% Operating Margin -10412.04% Pretax Margin -10356.48% Profit Margin -10069.91% EBITDA Margin -10412.04% EBIT Margin -10412.04% FCF Margin -9065.74%
Dividends & Yields BNTC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BNTC is $24,
which is 101.5% higher than the current price. The consensus rating is "Buy".
Price Target $24 Price Target Difference 101.5% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 26, 2023. It was a
backward
split with a ratio of 1:17.
Last Split Date Jul 26, 2023 Split Type backward Split Ratio 1:17
Scores Altman Z-Score 21.56 Piotroski F-Score 3
